PRECISION is funded by Cancer Research UK and Dutch Cancer Society
News
PRECISION publishes review article – Ductal carcinoma in situ: to treat or not to treat, that is the question
On 9th July, PRECISION published its latest review article in the British Journal of Cancer. Here, the authors present a global perspective of what it means to be diagnosed with DCIS - its medical, social and emotional impact on lives of women with DCIS. The paper...
Becoming Professor…
On 24th May 2019, Jelle Wesseling delivered his inaugural lecture as professor on "Borstkaker: minder is meer" (Breast cancer: less is more) at Groot Auditorium van het Academiegebouw, Leiden. A one day symposium - Finding Balance Between Over- and Under treatment of...
‘Over-diagnosis and over-treatment of breast cancer is a travesty in women’s healthcare’
Donna Pinto, PRECISION patient advocate from the USA interviews with Life Health and Wellbeing. Click below to read the full article...
PRECISION @ Association of Breast Surgery Conference 2019 – Future Management of DCIS
Prof. Dr. Alastair Thompson (Baylor College of Medicine) and Prof. Dr. Jelle Wesseling (NKI) from PRECISION delivered lectures in the session "Future Management of DCIS" at the Association of Breast Surgery Conference 2019, Glasgow along with Prof. Dr. Louise Jones...
DCIS Dilemmas – clinician and patient advocate interactive session 13th June, NKI, Amsterdam
Are you a clinician or a health care professional involved with DCIS patients? Come and join us in person or via video conferencing on our DCIS Dilemmas session on 13th June@ NKI, Amsterdam For registration write to precision@nki.nl . Last date for registration 7th...
PRECISION@ESMO Breast Cancer Annual Congress 2019
PRECISION patient advocate Ellen Verschuur-van der Voort and Lead PI Jelle Wesseling attended the ESMO Breast Cancer Annual Congress on 3rd May 2019 in Berlin. Ellen and Jelle were invited to deliver talks at the session: In Collaboration with Europa Donna : Patient...
A new study reveals – 6 prognostic factors which may predict invasive breast cancer recurrence after DCIS diagnosis
A new meta-analysis from the Wesseling lab at NKI indicate 6 prognostic factors which may predict invasive breast cancer recurrence after DCIS diagnosis. Lindy Visser, PhD student in the Wesseling group, together with colleagues from NKI published a systematic review...
PRECISION Annual Review Meeting 23-25 January 2019
PRECISION steering group members, collaborators and patient advocates convened for the second CRUK annual review meeting at Windsor from 23rd-25th January 2019. For more pictures and videos of the meeting click here
San Antonio Breast Cancer Symposium (SABCS) 2018
The San Antonio Breast Cancer Symposium 2018 was attended by Jelle Wesseling, Alastair Thompson, Shelley Hwang, Daniel Rea and Deborah Collyar from the PRECISION team. A poster was presented by Jelle Wesseling describing new insights into relatedness of DCIS and...
